# Peoples Bancorp Inc: financial statements, quarterly

PEBO · Nasdaq · CIK 318300 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pebo.md) · [Financials](/companies/pebo/financials.md) · [Filings](/companies/pebo/filings.md) · [Insiders](/companies/pebo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pebo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.7 d](/filings/0000318300-26-000099.md) | [21.9](/filings/0000318300-25-000154.md) | [20.6](/filings/0000318300-25-000236.md) | [20.4](/filings/0000318300-25-000293.md) | [21.9 d](/filings/0000318300-26-000099.md) | [22.0](/filings/0000318300-26-000157.md) | [21.3](/filings/0000318300-26-000193.md) | [21.5](/filings/0000318300-26-000241.md) | [22.0 d](/filings/0000318300-26-000099.md) | [22.4](/filings/0000318300-26-000157.md) | [22.0](/filings/0000318300-26-000193.md) | [22.7](/filings/0000318300-26-000241.md) |
| Operating income | $m | [43.5 d](/filings/0000318300-26-000099.md) | [37.9](/filings/0000318300-25-000154.md) | [35.9](/filings/0000318300-25-000236.md) | [40.9](/filings/0000318300-25-000293.md) | [34.9 d](/filings/0000318300-26-000099.md) | [31.4](/filings/0000318300-26-000157.md) | [27.5](/filings/0000318300-26-000193.md) | [38.0](/filings/0000318300-26-000241.md) | [38.0 d](/filings/0000318300-26-000099.md) | [37.3](/filings/0000318300-26-000157.md) | [35.6](/filings/0000318300-26-000193.md) | [41.4](/filings/0000318300-26-000241.md) |
| Interest expense | $m | [36.9 d](/filings/0000318300-24-000140.md) | [41.0](/filings/0000318300-24-000195.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.7 d](/filings/0000318300-26-000099.md) | [8.3](/filings/0000318300-25-000154.md) | [6.9](/filings/0000318300-25-000236.md) | [9.2](/filings/0000318300-25-000293.md) | [7.9 d](/filings/0000318300-26-000099.md) | [7.0](/filings/0000318300-26-000157.md) | [6.2](/filings/0000318300-26-000193.md) | [8.5](/filings/0000318300-26-000241.md) | [6.2 d](/filings/0000318300-26-000099.md) | [8.3](/filings/0000318300-26-000157.md) | [7.7](/filings/0000318300-26-000193.md) | [8.8](/filings/0000318300-26-000241.md) |
| Net income | $m | [33.8 d](/filings/0000318300-26-000099.md) | [29.6](/filings/0000318300-25-000154.md) | [29.0](/filings/0000318300-25-000236.md) | [31.7](/filings/0000318300-25-000293.md) | [26.9 d](/filings/0000318300-26-000099.md) | [24.3](/filings/0000318300-26-000157.md) | [21.2](/filings/0000318300-26-000193.md) | [29.5](/filings/0000318300-26-000241.md) | [31.8 d](/filings/0000318300-26-000099.md) | [29.0](/filings/0000318300-26-000157.md) | [28.0](/filings/0000318300-26-000193.md) | [32.6](/filings/0000318300-26-000241.md) |
| Diluted EPS | $ per share | not reported | [0.84](/filings/0000318300-25-000154.md) | [0.82](/filings/0000318300-25-000236.md) | [0.89](/filings/0000318300-25-000293.md) | not reported | [0.68](/filings/0000318300-26-000157.md) | [0.59](/filings/0000318300-26-000193.md) | [0.83](/filings/0000318300-26-000241.md) | not reported | [0.81](/filings/0000318300-26-000157.md) | [0.78](/filings/0000318300-26-000193.md) | [0.91](/filings/0000318300-26-000241.md) |
| Basic EPS | $ per share | not reported | [0.85](/filings/0000318300-25-000154.md) | [0.83](/filings/0000318300-25-000236.md) | [0.90](/filings/0000318300-25-000293.md) | not reported | [0.69](/filings/0000318300-26-000157.md) | [0.60](/filings/0000318300-26-000193.md) | [0.83](/filings/0000318300-26-000241.md) | not reported | [0.82](/filings/0000318300-26-000157.md) | [0.79](/filings/0000318300-26-000193.md) | [0.92](/filings/0000318300-26-000241.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [427](/filings/0000318300-25-000093.md) | [430](/filings/0000318300-24-000195.md) | [236](/filings/0000318300-24-000302.md) | [284](/filings/0000318300-24-000375.md) | [218](/filings/0000318300-26-000099.md) | [187](/filings/0000318300-25-000154.md) | [186](/filings/0000318300-25-000236.md) | [190](/filings/0000318300-25-000293.md) | [189](/filings/0000318300-26-000241.md) | [190](/filings/0000318300-26-000157.md) | [180](/filings/0000318300-26-000193.md) | [301](/filings/0000318300-26-000241.md) |
| Total assets | $m | [9,157](/filings/0000318300-25-000093.md) | [9,271](/filings/0000318300-24-000195.md) | [9,226](/filings/0000318300-24-000302.md) | [9,140](/filings/0000318300-24-000375.md) | [9,254](/filings/0000318300-26-000099.md) | [9,246](/filings/0000318300-25-000154.md) | [9,541](/filings/0000318300-25-000236.md) | [9,624](/filings/0000318300-25-000293.md) | [9,650](/filings/0000318300-26-000241.md) | [9,648](/filings/0000318300-26-000157.md) | [9,540](/filings/0000318300-26-000193.md) | [9,652](/filings/0000318300-26-000241.md) |
| Total liabilities | $m | [8,104](/filings/0000318300-25-000093.md) | [8,209](/filings/0000318300-24-000195.md) | [8,149](/filings/0000318300-24-000302.md) | [8,015](/filings/0000318300-24-000375.md) | [8,143](/filings/0000318300-26-000099.md) | [8,108](/filings/0000318300-25-000154.md) | [8,387](/filings/0000318300-25-000236.md) | [8,441](/filings/0000318300-25-000293.md) | [8,443](/filings/0000318300-26-000241.md) | [8,432](/filings/0000318300-26-000157.md) | [8,304](/filings/0000318300-26-000193.md) | [8,424](/filings/0000318300-26-000241.md) |
| Long-term debt | $m | [216](/filings/0000318300-25-000093.md) | [236](/filings/0000318300-24-000195.md) | [234](/filings/0000318300-24-000302.md) | [237](/filings/0000318300-24-000375.md) | [238](/filings/0000318300-26-000099.md) | [237](/filings/0000318300-25-000154.md) | [232](/filings/0000318300-25-000236.md) | [227](/filings/0000318300-25-000293.md) | [204](/filings/0000318300-26-000241.md) | [185](/filings/0000318300-26-000157.md) | [156](/filings/0000318300-26-000193.md) | [155](/filings/0000318300-26-000241.md) |
| Short-term borrowings | $m | [650](/filings/0000318300-26-000099.md) | [513](/filings/0000318300-24-000195.md) | [483](/filings/0000318300-24-000302.md) | [176](/filings/0000318300-24-000375.md) | [193](/filings/0000318300-26-000099.md) | [19.2](/filings/0000318300-25-000154.md) | [397](/filings/0000318300-25-000236.md) | [484](/filings/0000318300-25-000293.md) | [436](/filings/0000318300-26-000241.md) | [506](/filings/0000318300-26-000157.md) | [589](/filings/0000318300-26-000193.md) | [704](/filings/0000318300-26-000241.md) |
| Shareholders' equity | $m | [1,054](/filings/0000318300-26-000099.md) | [1,062](/filings/0000318300-25-000236.md) | [1,078](/filings/0000318300-25-000293.md) | [1,125](/filings/0000318300-25-000293.md) | [1,112](/filings/0000318300-26-000241.md) | [1,138](/filings/0000318300-26-000193.md) | [1,153](/filings/0000318300-26-000241.md) | [1,183](/filings/0000318300-26-000241.md) | [1,207](/filings/0000318300-26-000241.md) | [1,216](/filings/0000318300-26-000193.md) | [1,237](/filings/0000318300-26-000241.md) | [1,228](/filings/0000318300-26-000241.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [30.6 d](/filings/0000318300-26-000099.md) | [37.0](/filings/0000318300-25-000154.md) | [32.1 d](/filings/0000318300-25-000236.md) | [34.1 d](/filings/0000318300-25-000293.md) | [40.0 d](/filings/0000318300-26-000099.md) | [34.3](/filings/0000318300-26-000157.md) | [50.7 d](/filings/0000318300-26-000193.md) | [14.4 d](/filings/0000318300-26-000241.md) | [35.3 d](/filings/0000318300-26-000099.md) | [34.5](/filings/0000318300-26-000157.md) | [56.1 d](/filings/0000318300-26-000193.md) | [48.7 d](/filings/0000318300-26-000241.md) |
| Capital expenditure | $m | [2.8 d](/filings/0000318300-26-000099.md) | [3.9](/filings/0000318300-25-000154.md) | [1.9 d](/filings/0000318300-25-000236.md) | [0.9 d](/filings/0000318300-25-000293.md) | [0.2 d](/filings/0000318300-26-000099.md) | [2.7](/filings/0000318300-26-000157.md) | [1.5 d](/filings/0000318300-26-000193.md) | [1.7 d](/filings/0000318300-26-000241.md) | [0.1 d](/filings/0000318300-26-000099.md) | [1.2](/filings/0000318300-26-000157.md) | [0.9 d](/filings/0000318300-26-000193.md) | [1.6 d](/filings/0000318300-26-000241.md) |
| Dividends paid | $m | [14.2 d](/filings/0000318300-26-000099.md) | [13.9](/filings/0000318300-25-000154.md) | [14.0 d](/filings/0000318300-25-000236.md) | [14.2 d](/filings/0000318300-25-000293.md) | [14.2 d](/filings/0000318300-26-000099.md) | [14.2](/filings/0000318300-26-000157.md) | [14.6 d](/filings/0000318300-26-000193.md) | [14.7 d](/filings/0000318300-26-000241.md) | [14.6 d](/filings/0000318300-26-000099.md) | [14.6](/filings/0000318300-26-000157.md) | [15.1 d](/filings/0000318300-26-000193.md) | [15.1 d](/filings/0000318300-26-000241.md) |
| Share repurchases | $m | [3.0 d](/filings/0000318300-26-000099.md) | [3.0](/filings/0000318300-25-000154.md) | [0.0 d](/filings/0000318300-25-000236.md) | [0.0 d](/filings/0000318300-25-000293.md) | [0.0 d](/filings/0000318300-26-000099.md) | [0.0](/filings/0000318300-26-000157.md) | [0.5 d](/filings/0000318300-26-000193.md) | [0.0 d](/filings/0000318300-26-000241.md) | [0.4 d](/filings/0000318300-26-000099.md) | [0.0](/filings/0000318300-26-000157.md) | [0.0 d](/filings/0000318300-26-000193.md) | [0.0 d](/filings/0000318300-26-000241.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.0](/filings/0000318300-24-000195.md) | [32.6](/filings/0000318300-24-000302.md) | [35.1](/filings/0000318300-24-000375.md) | [35.1](/filings/0000318300-25-000154.md) | [35.1](/filings/0000318300-25-000236.md) | [35.2](/filings/0000318300-25-000293.md) | [35.3](/filings/0000318300-26-000157.md) | [35.3](/filings/0000318300-26-000193.md) | [35.4](/filings/0000318300-26-000241.md) | [35.5](/filings/0000318300-26-000157.md) | [35.6](/filings/0000318300-26-000193.md) | [35.7](/filings/0000318300-26-000241.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,959,609 at 2026-10-28, from the cover of the [10-Q filed 2026-10-29](/filings/0000318300-26-000241.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 13:58 ET. No prices; not investment advice.